Literature DB >> 3524421

Successful treatment of a pancreatic Nocardia asteroides abscess with amikacin and surgical drainage.

B Meier, U Metzger, F Müller, W Siegenthaler, R Lüthy.   

Abstract

A retroperitoneal Nocardia asteroides abscess was diagnosed in a 76-year-old patient. Trimethoprimsulfamethoxazole treatment for 6.5 weeks failed after surgical drainage of the abscess, and superinfection occurred. Subsequent treatment with amikacin resulted in a cure after 7 weeks. Amikacin might significantly shorten the duration of treatment in disseminated nocardiosis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3524421      PMCID: PMC180381          DOI: 10.1128/AAC.29.1.150

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  In vitro susceptibility of Nocardia asteroides to amikacin.

Authors:  J R Dalovisio; G A Pankey
Journal:  Antimicrob Agents Chemother       Date:  1978-01       Impact factor: 5.191

2.  Factors affecting survival in nocardiosis.

Authors:  C A Presant; P H Wiernik; A A Serpick
Journal:  Am Rev Respir Dis       Date:  1973-12

3.  Abdominal nocardiosis in a Sudanese girl.

Authors:  S A Salfield; B I Duerden; J A Dickson; R D Milner
Journal:  Eur J Pediatr       Date:  1983-04       Impact factor: 3.183

4.  Successful treatment of Nocardia asteroides infection with amikacin.

Authors:  R Yogev; T Greenslade; C F Firlit; P Lewy
Journal:  J Pediatr       Date:  1980-04       Impact factor: 4.406

5.  Trimethoprim/sulfamethoxazole-resistant Nocardia asteroides causing multiple hepatic abscesses. Successful treatment with ampicillin, amikacin, and limited computed tomography-guided needle aspiration.

Authors:  F R Cockerill; R S Edson; G D Roberts; J C Waldorf
Journal:  Am J Med       Date:  1984-09       Impact factor: 4.965

6.  Use of trimethoprim-sulfamethoxazole for treatment of infections due to Nocardia.

Authors:  R J Wallace; E J Septimus; T W Williams; R H Conklin; T K Satterwhite; M B Bushby; D C Hollowell
Journal:  Rev Infect Dis       Date:  1982 Mar-Apr

7.  Treatment of experimental nocardiosis in mice: comparison of amikacin and sulfonamide.

Authors:  R J Wallace; E J Septimus; D M Musher; M B Berger; R R Martin
Journal:  J Infect Dis       Date:  1979-08       Impact factor: 5.226

8.  Trimethoprim-sulfamethoxazole therapy for Nocardia infections.

Authors:  R A Smego; M B Moeller; H A Gallis
Journal:  Arch Intern Med       Date:  1983-04

9.  Susceptibility of Nocardia asteroides to 46 antibiotics, including 22 beta-lactams.

Authors:  L Gutmann; F W Goldstein; M D Kitzis; B Hautefort; C Darmon; J F Acar
Journal:  Antimicrob Agents Chemother       Date:  1983-02       Impact factor: 5.191

Review 10.  Human nocardiosis. A clinical review with selected case reports.

Authors:  W A Curry
Journal:  Arch Intern Med       Date:  1980-06
  10 in total
  5 in total

1.  Nocardia asteroides pneumonia complicating low dose methotrexate treatment of refractory rheumatoid arthritis.

Authors:  J J Cornelissen; L J Bakker; M J Van der Veen; M Rozenberg-Arska; J W Bijlsma
Journal:  Ann Rheum Dis       Date:  1991-09       Impact factor: 19.103

2.  Antimicrobial susceptibilities of regional pathogenic strains of Nocardia isolated from mycetomas.

Authors:  E L Durán; A van Gelderen de Komaid
Journal:  Mycopathologia       Date:  1995-09       Impact factor: 2.574

Review 3.  Nocardia species: host-parasite relationships.

Authors:  B L Beaman; L Beaman
Journal:  Clin Microbiol Rev       Date:  1994-04       Impact factor: 26.132

4.  Amikacin-containing regimens for treatment of nocardiosis in immunocompromised patients.

Authors:  F W Goldstein; B Hautefort; J F Acar
Journal:  Eur J Clin Microbiol       Date:  1987-04       Impact factor: 3.267

5.  Disseminated Nocardia cyriacigeorgia causing pancreatitis in a haploidentical stem cell transplant recipient.

Authors:  Jason Chen; Jonathan Pan; Joanne Filicko-O'Hara; Margaret Kasner; Phyllis Flomenberg
Journal:  IDCases       Date:  2017-06-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.